Literature DB >> 9536388

Cold-induced coronary Raynaud's phenomenon in patients with systemic sclerosis.

J Lekakis1, M Mavrikakis, M Emmanuel, V Prassopoulos, S Papazoglou, C Papamichael, D Moulopoulou, P Kostamis, S Stamatelopoulos, S Moulopoulos.   

Abstract

OBJECTIVE: Cardiac involvement with myocardial-band necrosis is common in systemic sclerosis. One possible explanation is that an underlying vasomotor abnormality accounts for these histologic findings. To shed light on this issue we investigated the existence of "myocardial Raynaud's phenomenon" in such patients.
METHODS: We examined 25 patients with systemic sclerosis and 14 patients with systemic lupus erythematosus or rheumatoid arthritis, using cold pressor and dipyridamole-thallium-201 scintigraphy.
RESULTS: Twenty-three patients with systemic sclerosis and 13 patients with lupus erythematosus or rheumatoid arthritis had normal perfusion during dipyridamole imaging. Seven scleroderma patients with normal dipyridamole test presented cold-induced transient myocardial ischemia, while none of the control patients had cold-induced ischemia (p = 0.034). All patients with cold-induced ischemic defects presented long-standing Raynaud's phenomenon (> 5 years); of the 14 patients with long-standing Raynaud's phenomenon 7 presented ischemic thallium-201 defects; of the remaining 9 patients with Raynaud's phenomenon of short duration (< 5 years) none presented cold-induced ischemia (p = 0.019).
CONCLUSION: Patients with systemic sclerosis and long-standing Raynaud's phenomenon, even in the presence of normal myocardial perfusion during pharmacological vasodilation with dipyridamole, may present cold-induced myocardial ischemia, a functional Raynaud's phenomenon of the heart.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9536388

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  7 in total

Review 1.  A critical view on cardiovascular risk in systemic sclerosis.

Authors:  Antonios Psarras; Stergios Soulaidopoulos; Alexandros Garyfallos; George Kitas; Theodoros Dimitroulas
Journal:  Rheumatol Int       Date:  2016-07-12       Impact factor: 2.631

2.  Pulmonary vasospasm in systemic sclerosis: noninvasive techniques for detection.

Authors:  Gregory J Keir; Arjun Nair; Stamatia Giannarou; Guang-Zhong Yang; Paul Oldershaw; S John Wort; Peter MacDonald; David M Hansell; Athol U Wells
Journal:  Pulm Circ       Date:  2015-09       Impact factor: 3.017

3.  The association of Raynaud's syndrome with rheumatoid arthritis--a meta-analysis.

Authors:  Peter Hartmann; Melvin Mohokum; Peter Schlattmann
Journal:  Clin Rheumatol       Date:  2011-04-02       Impact factor: 2.980

4.  Scleroderma heart disease: an unusual cause of positive antimyosin cardiac imaging.

Authors:  J Lekakis; M Mavrikakis; V Prassopoulos; S Gerali; N Sifakis; P Kostamis; S Stamatelopoulos
Journal:  J Nucl Cardiol       Date:  1999 Jan-Feb       Impact factor: 5.952

5.  Nailfold videocapillaroscopy results in patients with rheumatoid arthritis.

Authors:  Sinem Sag; Mustafa Serdar Sag; Ibrahim Tekeoglu; Ayhan Kamanli; Kemal Nas; Yıldıray Aydın
Journal:  Clin Rheumatol       Date:  2017-06-04       Impact factor: 2.980

6.  Identification of myocardial damage in systemic sclerosis: a nuclear cardiology approach.

Authors:  Kenichi Nakajima; Shinro Matsuo; Minoru Hasegawa; Seigo Kinuya; Kazuhiko Takehara
Journal:  Int J Rheumatol       Date:  2010-08-31

Review 7.  Right Ventricle Remodeling and Function in Scleroderma Patients.

Authors:  Roxana Cucuruzac; Iolanda Muntean; Imre Benedek; Andras Mester; Nora Rat; Adriana Mitre; Monica Chitu; Theodora Benedek
Journal:  Biomed Res Int       Date:  2018-03-20       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.